News
/
Prabjot Hunjan joins Arriello
as Director of Global Drug Safety.
Arriello welcomes another senior pharmacovigilance leader to our growing team of PV experts.
Prabjot joins Arriello’s Pharmacovigilance team with over 16 years of experience across both clinical trials and post-marketing within European and Global PV operations, both in CROs and pharma, and with six years in management.
His CRO & pharma experience includes director-level management, leading and developing the Pharmacovigilance function whilst delivering Pharmacovigilance Quality and Process Improvements.
Prabjot has also acted as EU QPPV and Deputy on behalf of Marketing Authorization Holders in the EU and has worked within a large team as a program and product lead on a well-established MS product.
Prabjot is also a trained auditor and experienced in EU GDPR as a Data Protection Officer.
He will report to Arriello’s VP of Global Dug Safety @kieranodonnell
Latest news.
View allSonia has 20 years of experience in global and local pharmacovigilance in both large pharma and service provider organizations.
Our Chief Regulatory Officer Peter Embley will be speaking at the biotech focused Chief Medical Officer Summit 360 event in Boston April 3-4.
Sam has over 20 years strategic and operational experience and will develop and direct our clinical and non-clinical pharmacovigilance services and solutions.
